Page last updated: 2024-09-03

wr 99210 and dapsone

wr 99210 has been researched along with dapsone in 3 studies

Compound Research Comparison

Studies
(wr 99210)
Trials
(wr 99210)
Recent Studies (post-2010)
(wr 99210)
Studies
(dapsone)
Trials
(dapsone)
Recent Studies (post-2010) (dapsone)
590125,116379862

Protein Interaction Comparison

ProteinTaxonomywr 99210 (IC50)dapsone (IC50)
MyeloperoxidaseHomo sapiens (human)0.42
Dihydrofolate reductasePneumocystis carinii1.5

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19901 (33.33)18.7374
1990's2 (66.67)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Genther, CS; Smith, CS1
Cynamon, MH; Majumder, SK; Meyer, SC1
Cynamon, MH; DeStefano, MS; Shah, LM1

Other Studies

3 other study(ies) available for wr 99210 and dapsone

ArticleYear
Antifolate studies. Activities of 40 potential antimalarial compounds against sensitive and chlorguanide triazine resistant strains of folate-requiring bacteria and Escherichia coli.
    Journal of medicinal chemistry, 1977, Volume: 20, Issue:2

    Topics: Animals; Antimalarials; Bacteria; Drug Resistance, Microbial; Escherichia coli; Folic Acid; Folic Acid Antagonists; Malaria; Mice; Plasmodium berghei; Triazines

1977
In vitro activities of PS-15, a new dihydrofolate reductase inhibitor, and its cyclic metabolite against Mycobacterium avium complex.
    Antimicrobial agents and chemotherapy, 1995, Volume: 39, Issue:8

    Topics: Antimalarials; Cyclization; Dapsone; Folic Acid Antagonists; Humans; Microbial Sensitivity Tests; Mycobacterium avium Complex; Proguanil; Triazines

1995
Enhanced in vitro activity of WR99210 in combination with dapsone against Mycobacterium avium complex.
    Antimicrobial agents and chemotherapy, 1996, Volume: 40, Issue:11

    Topics: Anti-Bacterial Agents; Dapsone; Drug Synergism; Humans; Microbial Sensitivity Tests; Mycobacterium avium Complex; Triazines

1996
chemdatabank.com